目标:目前,对于股骨头坏死(ONFH)患者接受髋关节置换术(THA)治疗的适应症尚无共识或指导.本研究旨在探讨影响ONFH患者THA决策的因素,为ONFH患者行THA或髋关节保留的临床决策提供参考。
方法:这项回顾性病例对照研究涉及2016年7月至2021年10月来自中国股骨头坏死数据库(CONFHD)的ONFH患者数据。ONFH患者,首次就诊时受累的单侧髋关节根据是否接受过THA治疗分为THA组和非THA组.两组患者在性别方面的差异,咨询时的年龄,体重指数(BMI),病因学,起病侧,关联研究循环骨性(ARCO)阶段,髋关节功能,视觉模拟量表(VAS),等。进行了分析。采用多因素二项logistic回归分析评价ONFH患者首次就诊时接受THA的危险因素。
结果:共招募了640名患者进行分析,其中THA组209例,非THA组431例。单因素分析结果显示,两组患者在以下6个指标上存在显著差异:年龄(59vs.46,Z=-9.58,p<0.001),疾病持续时间(78vs.17,Z=-16.14,p<0.001),性别构成(χ2=8.09,p=0.004),疾病病因(χ2=33.04,p<0.001),ARCO分期(χ2=334.86,p<0.001),髋关节屈曲(χ2=172.33,p<0.001)。然而,两组VAS比较(Z=-0.82,p=0.41),BMI(Z=-1.35,p=0.18),发病侧(χ2=1.53,p=0.22)无明显差异。结果回归分析表明,咨询时的年龄,疾病的持续时间,ARCO阶段,髋关节功能影响患者是否应该接受THA的决策。受试者工作特征曲线(ROC)分析结果显示,上述指标在预测ONFH患者是否接受THA治疗方面是令人满意的。以上述四个指标为综合指标的回归模型在预测是否执行THA方面表现令人满意,曲线下面积(AUC)为93.94%。
结论:这些因素,例如年龄,疾病的持续时间,ARCO阶段,在我们的临床实践中,在决定是否进行THA之前,应全面考虑髋关节屈曲功能。
OBJECTIVE: At present, there is no consensus or guidance on indications for osteonecrosis of the femoral head (ONFH) patients to receive hip arthroplasty (THA) treatment. This study aims to explore the factors that influence the decision-making for THA in patients with ONFH, and to provide references for clinical decision for ONFH patients to be indicated for THA or hip preservation.
METHODS: This retrospective
case-control study involved data for ONFH patients from July 2016 to October 2021 from the China Osteonecrosis of the Femoral Head Database (CONFHD). The patients with ONFH, and unilateral hip affected at the first visit were divided into THA group and non-THA group according to if they had undergone THA treatment. The differences between the two groups of patients in terms of gender, age at the time of consultation, body mass index (BMI), etiology, onset side, association research circulation osseous (ARCO) stage, hip joint function, visual analog scale (VAS), etc. were analyzed. Multivariate binomial logistic regression analysis was then applied to evaluate the risk factors of ONFH patients who underwent THA during the first visit.
RESULTS: A total of 640 patients were recruited for analysis, including 209 cases from the THA group and 431 cases from the non-THA group. The results of univariate analysis showed that the two groups of patients were significantly different in the following six indicators: age (59 vs. 46, Z = -9.58, p < 0.001), duration of disease (78 vs. 17, Z = -16.14, p < 0.001), gender composition (χ2 = 8.09, p = 0.004), disease etiology (χ2 = 33.04, p < 0.001), ARCO stage (χ2 = 334.86, p < 0.001), flexion of hip joint (χ2 = 172.33, p < 0.001). However, the comparison between the two groups on VAS (Z = -0.82, p = 0.41), BMI (Z = -1.35, p = 0.18), and onset side (χ2 = 1.53, p = 0.22) did not obviously differ. The results regression analysis showed that the age at the time of consultation, duration of disease, ARCO stage, and the hip joint function affected the decision making if the patients should undergo THA. The results of receiver operating characteristic curve (ROC) analysis showed that aforementioned indicators were satisfactory in predicting whether patients with ONFH would be treated with THA. The regression model using the above four indicators as comprehensive indicators has satisfactory performance in predicting whether to perform THA, and the area under the curve (AUC) is 93.94%.
CONCLUSIONS: These factors such as age, duration of disease, ARCO stage, and hip flexion function should be considered comprehensively before making decisions to perform THA or not in our clinical practice.